Financial Contrast: Glucose Health (GLUC) vs. Its Peers

Glucose Health (OTCMKTS:GLUCGet Free Report) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare Glucose Health to related businesses based on the strength of its earnings, dividends, institutional ownership, valuation, risk, profitability and analyst recommendations.

Volatility and Risk

Glucose Health has a beta of 3.49, indicating that its stock price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.24, indicating that their average stock price is 24% more volatile than the S&P 500.

Valuation & Earnings

This table compares Glucose Health and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Glucose Health $540,000.00 -$420,000.00 -9.32
Glucose Health Competitors $312.45 million -$48.92 million -8.33

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

15.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 20.9% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Glucose Health -75.00% N/A N/A
Glucose Health Competitors -40.08% -251.32% -7.52%

Analyst Ratings

This is a summary of current ratings for Glucose Health and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glucose Health 0 0 0 0 N/A
Glucose Health Competitors 272 554 990 74 2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 46.32%. Given Glucose Health’s peers higher probable upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Summary

Glucose Health peers beat Glucose Health on 6 of the 10 factors compared.

Glucose Health Company Profile

(Get Free Report)

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.